secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harpoon Therapeutics, Inc. (—)
CIK:        0001708493
Form:       8-K
Filed at:   2023-09-29T23:59:59+00:00
Accession:  0001193125-23-247523
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Harpoon Therapeutics receives Nasdaq delisting notice for failure to meet minimum equity requirement
--------------------------------------------------------------------------------

- On Sept 27, 2023, Nasdaq notified Harpoon of failure to meet minimum $2.5M equity requirement for continued listing on Capital Market.
- Company was granted a 180-day extension to Sept 26, 2023, but did not provide evidence of compliance by deadline.
- Harpoon plans to request a hearing before Nasdaq Hearings Panel; such request would stay any further delisting action.
- Previously, on Sept 12, 2023, Harpoon transferred from Nasdaq Global Market to Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708493/000119312523247523/0001193125-23-247523-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708493/000119312523247523/d585252d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-247523

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer